Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity
Abstract
:1. Introduction
2. Case Presentation
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Kounis, N.; Zavras, G. Histamine-Induced Coronary Artery Spasm: The Concept of Allergic Angina. Br. J. Clin. Pr. 1991, 45, 121–128. [Google Scholar]
- Mastoris, I.; Flynn, B. Kounis Syndrome or Allergic Angina: An Elusive Entity. J. Cardiothorac. Vasc. Anesth. 2022, 36, 2077–2079. [Google Scholar] [CrossRef] [PubMed]
- Li, J.; Zheng, J.; Zhou, Y.; Liu, X.; Peng, W. Acute Coronary Syndrome Secondary to Allergic Coronary Vasospasm (Kounis Syndrome): A Case Series, Follow-up and Literature Review. BMC Cardiovasc. Disord. 2018, 18, 42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Johnson, J.L.; Jackson, C.L.; Angelini, G.D.; George, S.J. Activation of Matrix-Degrading Metalloproteinases by Mast Cell Proteases in Atherosclerotic Plaques. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 1707–1715. [Google Scholar] [CrossRef] [Green Version]
- Theoharides, T.C.; Kalogeromitros, D. The Critical Role of Mast Cells in Allergy and Inflammation. Ann. N. Y. Acad. Sci. 2006, 1088, 78–99. [Google Scholar] [CrossRef] [Green Version]
- Arshad, M.; Vijay, V.; Floyd, B.C.; Marks, B.; Sarabu, M.R.; Wolin, M.S.; Gupte, S.A. Thromboxane Receptor Stimulation Suppresses Guanylate Cyclase-Mediated Relaxation of Radial Arteries. Ann. Thorac. Surg. 2006, 81, 2147–2154. [Google Scholar] [CrossRef]
- Kounis, N.G.; Tsigkas, G.; Almpanis, G.; Kouni, S.N.; Kounis, G.N.; Mazarakis, A. Anaphylaxis-Induced Hyperfibrinogenolysis and the Risk of Kounis Syndrome: The Dual Action of Tryptase. Am. J. Emerg. Med. 2011, 29, 1229–1230. [Google Scholar] [CrossRef]
- Peláez-Pérez, J.M.; Sánchez Casado, M.; Álvarez-Twose, I.; Kounis, N.G. Amoxicillin-Clavulanic Acid-Induced Type II Kounis Syndrome during General Anaesthesia Complicated with Hypoxic-Ischaemic Encephalopathy. Rev. Española Anestesiol. Y Reanim. 2021, 68, 161–164. [Google Scholar] [CrossRef]
- Kounis, N.G.; Koniari, I.; Tsigkas, G.; Chourdakis, E.; Velissaris, D.; Soufras, G.D.; Hahalis, G. Death Following Ceftazidime-Induced Kounis Syndrome: Diagnostic Considerations in the Realm of Forensic Pathology. Med.-Leg. J. 2020, 88, 48–49. [Google Scholar] [CrossRef]
- Çakmak, A.; Keskin, G. Kounis Syndrome: Is Ceftriaxone or Metronidazole Responsible for Acute Myocardial Infarction? A Rare Case. Anatol. J. Cardiol. 2021, 25, 451–452. [Google Scholar] [CrossRef]
- Wang, C.; Deng, Z.; Song, L.; Sun, W.; Fang, W.; Li, Z. Analysis of Clinical Characteristics of Kounis Syndrome Induced by Contrast Media. Am. J. Emerg. Med. 2022, 52, 203–207. [Google Scholar] [CrossRef] [PubMed]
- Gogos, C.; Sachpekidis, V.; Moschovidis, V.; Styliadis, I.; Kounis, N.G. Kounis Syndrome in a COVID-19 Patient Following Intravenous Administration of Azithromycin. J. Investig. Allergol. Clin. Immunol. 2021, 32, 75–76. [Google Scholar] [CrossRef] [PubMed]
- Kounis, N.G.; Koniari, I.; Mplani, V.; Kouni, S.N.; Plotas, P.; Tsigkas, G. Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination: Is Kounis Syndrome the Culprit? Am. J. Cardiol. 2022, 162, 207. [Google Scholar] [CrossRef] [PubMed]
- Sriwijitalai, W.; Wiwanitkit, V. COVID-19 Vaccine, Myocardial Infarction and Kounis Syndrome. QJM Int. J. Med. 2022, 115, 193. [Google Scholar] [CrossRef] [PubMed]
- Fialho, I.; Mateus, C.; Martins-dos-Santos, G.; Pita, J.; Cabanelas, N.; Baptista, S.B.; Roque, D. Recurrent Kounis Syndrome—A Life-Threatening Event after COVID-19 Vaccine Administration. J. Cardiol. Cases 2022, 25, 400–403. [Google Scholar] [CrossRef] [PubMed]
- Almpanis, G.; Siahos, S.; Karogiannis, N.C.; Mazarakis, A.; Niarchos, C.; Kounis, G.N.; Kounis, N.G. Kounis Syndrome: Two Extraordinary Cases. Int. J. Cardiol. 2011, 147, e35–e38. [Google Scholar] [CrossRef]
- Almeida, J.; Ferreira, S.; Malheiro, J.; Fonseca, P.; Caeiro, D.; Dias, A.; Ribeiro, J.; Gama, V. A Rare Cause of Acute Coronary Syndrome: Kounis Syndrome. Revista Portuguesa Cardiologia 2016, 35, 699.e1–699.e4. [Google Scholar] [CrossRef]
- Kounis, N.G. Kounis Syndrome: An Update on Epidemiology, Pathogenesis, Diagnosis and Therapeutic Management. Clin. Chem. Lab. Med. 2016, 54, 1545–1559. [Google Scholar] [CrossRef] [Green Version]
- Naranjo, C.A.; Busto, U.; Sellers, E.M.; Sandor, P.; Ruiz, I.; Roberts, E.A.; Janacek, E.; Domecq, C.; Greenblatt, D.J. A Method for Estimating the Probability of Adverse Drug Reactions. Clin. Pharmacol. Ther. 1981, 30, 239–245. [Google Scholar] [CrossRef]
- Kounis, N.G.; Koniari, I.; Velissaris, D.; Tzanis, G.; Hahalis, G. Kounis Syndrome—Not a Single-Organ Arterial Disorder but a Multisystem and Multidisciplinary Disease. Balk. Med. J. 2019, 36, 212–221. [Google Scholar] [CrossRef]
- Virani, S.; Khan, A.; Mendoza, C. Takotsubo Cardiomyopathy, or Broken-Heart Syndrome—PubMed. Available online: https://pubmed.ncbi.nlm.nih.gov/17420797/ (accessed on 3 May 2022).
- Frustaci, A.; Verardo, R.; Labbadia, G.; Menafra, V.; Galea, N.; Antonio Russo, M. Hypersensitivity Myocarditis Following Deferasirox Administration. Circ. Cardiovasc. Imaging 2022, 15, e013702. [Google Scholar] [CrossRef] [PubMed]
- Abdelghany, M.; Subedi, R.; Shah, S.; Kozman, H. Kounis Syndrome: A Review Article on Epidemiology, Diagnostic Findings, Management and Complications of Allergic Acute Coronary Syndrome. Int. J. Cardiol. 2017, 232, 1–4. [Google Scholar] [CrossRef] [PubMed]
- Lexicomp® Drug Interactions-UpToDate. Available online: https://www-uptodate-com.ez.urosario.edu.co/drug-interactions/?source=responsive_home#di-disclaimer (accessed on 26 October 2021).
- Sciatti, E.; Vizzardi, E.; Cani, D.S.; Castiello, A.; Bonadei, I.; Savoldi, D.; Metra, M.; D’Aloia, A. Kounis Syndrome, a Disease to Know: Case Report and Review of the Literature. Monaldi Arch. Chest. Dis. 2018, 88, 9–14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Navarro-Navajas, A.; Casallas, I.; Isaza, D.; Ortiz, P.; Baracaldo-Santamaría, D.; Calderon-Ospina, C.-A. Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity. Medicina 2022, 58, 855. https://doi.org/10.3390/medicina58070855
Navarro-Navajas A, Casallas I, Isaza D, Ortiz P, Baracaldo-Santamaría D, Calderon-Ospina C-A. Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity. Medicina. 2022; 58(7):855. https://doi.org/10.3390/medicina58070855
Chicago/Turabian StyleNavarro-Navajas, Alberto, Ingrid Casallas, Daniel Isaza, Paola Ortiz, Daniela Baracaldo-Santamaría, and Carlos-Alberto Calderon-Ospina. 2022. "Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity" Medicina 58, no. 7: 855. https://doi.org/10.3390/medicina58070855